Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,033,667
+$11,033,667 QoQ
Shares Held
258,642
Ownership
0.011%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#81
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Derivatives in SNY
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$7,883,211
PutShares
163,620
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOGAN CAPITAL MANAGEMENT INC holds $143,017,458 across 13 Drug Manufacturers - General names. SNY ranks #6 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,791 | $33,333,361 | |
| 2 | MRK |
Merck & Co., Inc.
|
155,292 | $19,955,022 | |
| 3 | ABBV |
AbbVie Inc.
|
77,182 | $19,422,078 | |
| 4 | JNJ |
Johnson & Johnson
|
62,551 | $15,886,077 | |
| 5 | NVS |
Novartis AG
|
73,584 | $11,532,084 | |
| 6 | SNY |
Sanofi
This page
|
258,642 | $11,033,667 | |
| 7 | PFE |
Pfizer Inc
|
442,396 | $10,652,895 | |
| 8 | GSK |
GSK plc
|
141,076 | $7,395,203 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,033,667 | 258,642 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,883,211 | 163,620 | Put | Sole | 2026-05-08 | |
| 2025-12-31 | $7,141,210 | 147,363 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,276,986 | 132,987 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,614,346 | 116,215 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $4,868,223 | 87,779 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $4,114,019 | 85,300 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,909,442 | 85,189 | Shares | Sole | 2024-12-06 | |
| 2024-06-30 | $3,950,255 | 81,415 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,114,378 | 84,658 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,543,710 | 71,259 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,695,956 | 68,903 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,512,339 | 65,164 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,652,724 | 67,121 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,234,591 | 66,789 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,447,955 | 64,386 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,946,416 | 58,893 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,630,918 | 51,245 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,410,210 | 48,108 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,997,147 | 41,426 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,155,689 | 40,936 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $1,821,562 | 36,829 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,738,792 | 35,785 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,887,946 | 37,631 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,809,773 | 35,451 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,488,928 | 34,056 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||